Adenovirus vector infection of chronic lymphocytic leukemia B cells

Blood

Volumn 88, Issue 12, 1996, Pages 4676-4683

  Cantwell, Mark J ^a   Sharma, Sanjai ^a   Friedmann, Theodore ^a   Kipps, Thomas J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE ACTIVATION; CHRONIC LYMPHATIC LEUKEMIA; CROSS LINKING; FLOW CYTOMETRY; GENE DELETION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0029855930     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4676.bloodjournal88124676     Document Type: Article

References (27)

1. Kipps TJ: Chronic lymphocytic leukemia and related diseases, in Beutler E, Lichtman MA, Coller BS, Kipps TJ: (eds): Williams Hematology. New York, NY, McGraw-Hill, 1995, p 1017
2. Yang Y, Ertl HC, Wilson JM: MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433, 1994
3. Yang Y, Li Q, Ertl HC, Wilson JM: Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004, 1995
4. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925, 1993
5. Ranheim EA, Kipps TJ: Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: Complex regulation by IL-4, IL-10, and CD40L. Cell Immunol 161:226, 1995
6. Ranheim EA, Cantwell MJ, Kipps TJ: Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 85:3556, 1995
7. Buschle M, Brenner MK, Chen IS, Drexler HG, Gignac SM, Rooney CM: Transfection and gene expression in normal and malignant primary B lymphocytes. J Immunol Methods 133:77, 1990
8. Trapnell BC, Gorziglia M: Gene therapy using adenoviral vectors. Curr Opin Biotechnol 5:617, 1994
9. Kozarsky KF, Wilson JM: Gene therapy: Adenovirus vectors. Curr Opin Genet Dev 3:499, 1993
10. Graham FL, Prevec L: Adenovirus-based expression vectors and recombinant vaccines. Biotechnology 20:363, 1992
11. Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59, 1977
12. Cheresh DA, Spiro RC: Biosynthetic and functional properties of an arg-gly-asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen and von Willebrand factor. J Biol Chem 262:17703, 1987
13. 5 contribute to cell attachment to vitronectin but differently distribute on the cell surface. J Cell Biol 113:919, 1991
14. Clark EA, Ledbetter JA: Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 83:4494, 1986
15. Spessot R, Inchley K, Hupel TM, Bacchetti S: Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: Effects on adenovirus gene expression and replication. Virology 168:378, 1989
16. Townsend SE, Allison JP: Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259:368, 1993
17. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745, 1987
18. Fiering SN, Roederer M, Nolan GP, Micklem DR, Parks DR, Herzenberg LA: Improved FACS-Gal: Flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry 12:291, 1991
19. Kipps TJ, Meisenholder GW, Robbins BA: New developments in flow cytometric analyses of lymphocyte markers. J Clin Lab Anal 12:237, 1992
20. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309, 1993
21. Zheng CY, Pabello P, Maksymiuk AW, Skinnider LF: Establishment of cell lines derived from chronic lymphocytic leukaemic cells by transfection with myc and ras. Br J Haematol 93:681, 1996
22. Wattel E, Vanrumbeke M, Abina MA, Gambier N, Preudhomme C, Haddada H, Fenaux P: Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia 10:171, 1996
23. Young DC, Kingsley SD, Ryan KA, Dutko FJ: Selective inactivation of eukaryotic beta-galactosidase in assays for inhibitors of HIV-1 TAT using bacterial beta-galactosidase as a reporter enzyme. Anal Biochem 215:24, 1993
24. Sprunck G, Wigand R: Stabilization of adenovirus infectivity against thermoinactivation by lowered ionic strength. Med Microbiol Immunol (Berl) 170:37, 1981
25. Young CS: Heat-stable variant of human adenovirus type 5: Characterization and use in three-factor crosses. J Virol 15:1168, 1975
26. Kipps TJ: Immunohistochemistry, in Beutler E, Lichtman MA, Coller BS, Kipps TJ: (eds): Williams Hematology. New York, NY, McGraw-Hill, 1995, p L63
27. Dranoff G, Mulligan RC: Gene transfer as cancer therapy. Adv Immunol 58:417, 1995